Abstract Exposure to secondhand tobacco smoke (SHS) is a well-established risk factor for cardiovascular disease and lung cancer in nonsmoking adults. However, few studies have focused on the health consequences of exposure to SHS in older adults. This is the first study to assess the association between SHS and the frailty syndrome in the nonsmoking older adult population. Cross-sectional study was conducted among 2059 nonsmoking adults aged ≥60 years who participated in the third US National Health and Nutrition Examination Survey and had completed a physical examination. Exposure to SHS was assessed by serum cotinine concentrations and by self-reported data from the home questionnaire. Frailty was ascertained with a slight modification of the Fried criteria. Analyses were performed with logistic regression and adjusted for the main confounders. The median (interquartile range) concentration of serum cotinine was 0.095 (IQR 0.035-0.211) ng/mL. The prevalence of frailty was 6.0 %. The odds ratios (95 % confidence interval [CI]) of frailty comparing the second, third, and fourth to the lowest quartile of serum cotinine were, respectively, 1.44 (0.67-3.06), 1.46 (0.75-2.85), and 2.51 (1.06-5.95), p value for trend 0.04. An increased frequency of frailty was also observed in participants reporting to live with ≥2 smokers at home (odds ratio 5.37; 95 % CI 1.13-25.5). In the US nonsmoking older adult population, exposure to SHS was associated with an increased frequency of frailty. More efforts are needed to protect older adults from SHS, especially at home and in other areas not covered by smoke-free regulations.
. Older adults may be very susceptible to the effects of SHS because of age-related physiologic changes and coexisting health conditions (World Health Organization 1993) . Moreover, they may be at increased risk of involuntary exposure because they spend most time indoors and they are at higher risk of functional and economic dependency. Despite this, surprisingly, few studies have focused on the health consequences of exposure to SHS in older adults (Jaakkola 2002; Bentayeb et al. 2013) .
Frailty, a potentially preventable geriatric syndrome, is characterized by diminished physiologic reserve across multiple organ systems with decreased ability of the old individual to cope with environmental stressors (Clegg et al. 2013) . Frailty has been linked to increased risk for adverse outcomes in older adults, including falls (de Vries et al. 2013) , disability (Vermeulen 2011) , institutionalization (Fried et al. 2001) , and death Song et al. 2010) . Given the high frequency of frailty and its serious health and disability consequences, extensive research is being conducted to identify preventable risk factors and to understand mechanistic pathways.
In this study, we evaluated for the first time the association between SHS and frailty in the nonsmoking older adult population using data from the third US National Health and Nutrition Examination Survey (NHANES III).
Method

Study participants
NHANES III was a multistage, stratified, clustered probability survey of the US civilian noninstitutionalized population, conducted between 1988 and 1994 by the National Center for Health Statistics. The survey consisted of a household interview and a standardized physical examination performed in a mobile center. We limited our study to 3086 adults ≥60 years who reported Bhaving never smoked ≥100 cigarettes during their entire life^and had completed the physical examination. To ensure that we did not include smokers in the study, we also excluded participants who had serum cotinine concentrations above 10 ng/mL (N=993). Furthermore, we excluded 34 individuals with missing values in potential confounders (education, body mass index [BMI] , morbidities, or drug treatments), leading to a final analytical sample of 2059 individuals.
The study protocol was approved by the NHANES Institutional Review Board (IRB), and written informed consent was obtained from all participants.
Study variables
Secondhand tobacco smoke
Exposure to SHS was assessed by using self-reported data from the home questionnaire and serum cotinine, a specific biomarker of tobacco exposure (Benowitz 1996) . Serum cotinine was measured using high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. The limit of detection (LOD) for serum cotinine using this method was 0.05 ng/mL, and values under the LOD were replaced by the square root of 2 (0.035 ng/mL). Never smokers who presented serum cotinine concentrations ≥0.035 ng/mL or who self-reported living with at least one person who smoked were considered exposed to SHS.
Frailty
Frailty was assessed with a slight modification of the definition developed by Fried et al. (2001) in the Cardiovascular Health Study (CHS). Individuals meeting ≥3 of the following 5 criteria were considered as frail: (1) weakness, considered present if the individual answered Bsome difficulty,^Bmuch difficulty,^or Bunable to do it^to the question BHow much difficulty you have lifting or carrying something as heavy as 10 pounds?^; (2) exhaustion, defined as any of these responses Bsome difficulty,B much difficulty,^or Bunable to do it^to the question BHow much difficulty do you have walking from one room to the other on the same level?^; (3) low body weight, defined as BMI ≤18 kg/m 2 ; (4) Slow walking speed, defined as the worse quintile in the 8-ft walking speed test, adjusted for sex and height (Guralnik et al. 1994) ; and (5) low physical activity, considered present in individuals who answered Bless active^to the question BWhen compared to most men/women of your age, would you say that you are more active, less active or about the same?2
Potential confounders
Questionnaire information included sex, age, education, race/ethnicity, presence of comorbidities, and number of drug treatments used. Participants were asked about their previous history of cardiovascular disease (coronary heart disease, stroke congestive heart failure), hypertension, diabetes, osteoarticular disease (osteoporosis, rheumatoid arthritis, and osteoarthritis), respiratory disease (asthma, chronic bronchitis, or emphysema), and cancer. During the medical examination, blood pressure was measured three times with the participant seated for 5 min and using an appropriate-sized cuff. Hypertension was defined as self-reported physician diagnosis of high blood pressure or a mean systolic/diastolic blood pressure ≥140/90 mmHg. Finally, weight and height were measured in standardized conditions and BMI calculated as weight in kilogram divided by squared height in meters.
Statistical analyses
The association between SHS exposure and the presence of frailty was evaluated using logistic regression. Two sets of models were built, one in which serum cotinine was the main independent variable, and one in which exposure to SHS was defined according to the number of smokers at home. In the first set of models (Table 2) , participants were classified into quartiles of serum cotinine, with the lowest quartile (individuals with cotinine concentrations under the LOD) being the exposure reference. Additionally, ln-transformed cotinine was modeled as a continuous variable, and odds ratios comparing the 75th vs. the 25th percentiles of its distribution were derived. In the second set of models (Table 3) , participants were classified into three categories of exposure according to the number of smokers at home (0, 1, ≥2). All models were first adjusted for sex and age (model 1) and then further adjusted for education, ethnicity, BMI, morbidity, and number of drug treatments (model 2). Additionally, when the number of smokers at home was the main independent variable, a third model (model 3) further adjusting for the number of rooms per household was fitted.
Next, we estimated the association between cotinine concentrations and frequency of each frailty criterion (Table 4) . Again, two main models that accounted for the previously defined subsets of covariates were fitted.
Finally, to graphically evaluate the dose-response association between serum cotinine concentrations and frailty, serum cotinine concentrations were separately modeled using restricted cubic splines with knots at the 10th (0.035 ng/mL), 50th (0.095 ng/mL), and 90th (0.645 ng/mL) percentile of its distribution. In all analyses, we took sample weights and NHANES survey design into consideration by using the svy commands in Stata 13.
Results
The mean age of the population was 71.3 years and 74 % were women. The median (interquartile range) concentration of serum cotinine was 0.095 (IQR 0.035-0.211) ng/mL. Around 10 % of the population lived with at least one smoker. Compared to individuals whose serum cotinine concentration was undetectable, those with detectable cotinine concentrations were more likely to be men, had lower age, had lower medicine consumption, were more likely to be non-Hispanic black, and had lower education and greater BMI (Table 1) . Additionally, never smokers living with ≥1 smokers at home showed higher serum cotinine concentrations.
Among the study participants, 166 (6.0 %) were frail. Frailty was more common among women, those ≥74 years of age, non-Hispanic white and MexicanAmerican participants, and those with lower education. After multivariate adjustment, the odds ratio (95 % confidence interval [CI]) of frailty comparing the second, third, and fourth quartiles of serum cotinine to the lowest quartile were, respectively, 1.44 (0.67-3.06), 1.46 (0.75-2.85), and 2.51 (1.06-5.95), p value for trend 0.04 (Table 2 ). In spline regression models (Fig. 1) , the dose-response relationship was progressive over the range of serum cotinine concentrations (p value for the nonlinear component=0.11).
An increased frequency of frailty was also observed in participants living with smokers at home. Compared to those who do not live with smokers, the odds ratio (95 % CI) of frailty for those living with 1 or ≥2 smokers were, respectively, 1.46 (0.67-3.20) and 6.82 (1.83-25.4), p value for trend <0.01 (Table 3) . Results were similar after further adjustment for the number of rooms per household: 1.40 (0.58-3.41) and 5.37 (1.13-25.5), p value for trend 0.04. Table 4 shows the association between serum cotinine and the five components of the frailty syndrome. Higher serum cotinine was associated with higher frequency of weakness and with, a marginally significant, increased frequency of exhaustion.
Discussion
In this sample of nonsmoking older adults from the US general population, exposure to SHS, as measured using serum cotinine concentrations and self-reported information on the number of smokers at home, was associated with an increased prevalence of frailty. The (Oberg et al. 2011 ). Since then, many nations have passed bans on smoking in public spaces, but still millions of nonsmokers continue to be exposed to SHS in areas not covered by smoke-free regulations, including homes (Vital signs: nonsmokers' exposure to secondhand smoke-United States 1999). In the USA only, around 14 million of the noninstitutionalized, nonsmoking adults aged ≥60 years were exposed to SHS during 2007-2008 (Vital signs: nonsmokers' exposure to secondhand smoke-United States 1999). Moreover, according to the last Tobacco Use Supplement to the Current Population Survey, fewer than half of households with smokers in the USA have adopted smoke-free home rules (King et al. 2014) . Because a high proportion of adults ≥60 years reside in nursing homes and most countries have no laws regulating smoking in these settings, the magnitude of SHS exposure among older adults is likely to be greater.
Some studies have shown that active smoking can induce muscular damage and sarcopenia in the old age (Steffl et al. 2014) . In line with this finding, results from the Hallym Aging Study indicated that smoking was associated with higher frequency of decreased grip strength in men aged ≥65 years (Quan et al. 2013 ). In Table 3 Association between number of smokers at home and frequency of frailty among the US nonsmoking older population Model 1 was adjusted for age and sex. Model 2 was further adjusted for education, race/ethnicity, BMI, cardiovascular disease, hypertension, diabetes, osteoarticular disease, chronic respiratory disease, cancer, and number of drug treatments LOD limit of detection, Q quartile cross-sectional analyses, current smoking (Guessous et al. 2014 ) and consumption of ≥1 pack/day of cigarettes for ≥20 years (Hubbard et al. 2009 ) have been linked with an increased prevalence of frailty indicators, while some prospective cohort studies have shown that baseline smoking status is a strong predictor of frailty (Wang et al. 2013; Ottenbacher et al. 2009; Woods et al. 2005) and disability (Rist et al. 2014; Kim et al. 2013a; Ropponen et al. 2013; Wong et al. 2015) .
Since this is the first study to evaluate the association between SHS and frailty, we cannot compare our results with previous findings. However, there is evidence that SHS increases the risk of several diseases that are linked to frailty, including coronary heart disease, stroke, and lung cancer (Moritsugu 2007 ; U.S. Department of Health and Human Services 2014). Some studies have also linked SHS exposure in older adults with the risk of dementia (Chen et al. 2013a; Chen 2012; Barnes et al. 2010) , cognitive impairment (Chen et al. 2013b; Akhtar et al. 2013; Llewellyn et al. 2009 ), and worse scores in the mental health dimension of the SF-36 (Mesquita et al. 2015) . Among never smokers, high lifetime SHS exposure at home has been associated with decreased mineral density in both adult men and women (Holmberg et al. 2011 ) and with increased risk of osteoporosis in postmenopausal women (Kim et al. 2013b) . Finally, in a crosssectional study based on NHANES 1999-2002, authors found that SHS exposure among nonsmoking older adults was associated with reduced physical function and reduced gait speed (Akhtar et al. 2013) . Interestingly, in our study, the association with reduced physical function and reduced gait speed was not statistically significant, suggesting that SHS-related frailty was mainly driven through the high frequency of weakness and exhaustion.
This study has several strengths. First, it includes a large sample representative of the US general population aged ≥60 years. Second, the availability of serum cotinine, a specific biomarker of tobacco smoke exposure, reduces the possibility of exposure misclassification and allows for evaluating the dose-response relationship between SHS and frailty. And third, the study accounted for numerous covariates, so that residual confounding is likely to be small.
Some limitations of this study should also be acknowledged. First, the lack of prospective information limits reaching firm conclusions on SHS as a risk factor for frailty. Second, because the sample did not include institutionalized individuals, results cannot not be inferred to this population group. Third, we could not account for differences in cotinine metabolism. Because nicotine is primarily inactivated to cotinine by the hepatic enzyme CYP2A6, variations in its activity can modify serum cotinine concentrations. Similarly, there is some evidence that vegetarians and persons with higher intake of certain foods (i.e., almonds, broccoli, or garlic) may have falsely high levels of cotinine. However, we are not aware of reasons why the frequency of slower vs. faster nicotine metabolizers, or of those with high vs. low intake of these specific foods, could vary with frailty status. Finally, although cotinine levels correctly assess recent exposure to secondhand smoke, they may not reflect long-term exposure and especially past exposure. However, there is evidence that passive smoking is capable of precipitating acute changes in several physiological processes that are central to the pathogenesis of frailty. Specifically, short-term SHS exposure has been associated with increased circulating markers of inflammation (i.e., IL4, IL6, or TNF-α) (Flouris et al. 2009; Wilkinson et al. 2007; Jefferis et al. 2010; Chiu et al. 2011) ; changes in the immune response with increased white blood, lymphocyte, and granulocyte counts (Flouris et al. 2012) ; and elevated levels of markers of endothelial disfunction (Bonetti et al. 2011) . Additionally, previous research has found that serum cotinine among never smokers is associated with biomarkers of oxidative stress (i.e., 8-dihydro-2′-deoxyguanosine (Lodovici et al. 2005) ) and with markers of activation of inflammatory and coagulative processes (i.e., homocysteine (Clark et al. 2008; Venn and Britton 2007) , fibrinogen (Jefferis et al. 2010; Venn and Britton 2007) , factor VIII (Jefferis et al. 2010) ) that are known to be elevated in frail individuals (Gale et al. 2013; Li et al. 2011; Wu et al. 2009 ).
Conclusions
In the US nonsmoking older adult population, exposure to SHS was associated with an increased frequency of frailty. More efforts are needed to protect older adults from SHS, especially at home and in other areas not covered by smoke-free regulations.
